The global heparin market is expected to reach USD 11,507 billion by 2030, at a CAGR of 6.5% during the forecast period 2021 to 2030. In some individuals, blood clot formation is common during medical procedures such as surgery. Heparin is an anticoagulant drug that is used for the prevention of blood clot formation. The major reason behind the rising heparin market is increased cases of blood clots. This is due to increased chronic diseases, such as cardiovascular diseases, cancer, and others.
The global heparin market is expected to reach USD 11,507 billion by 2030, at a CAGR of 6.5% during the forecast period 2021 to 2030. In some individuals, blood clot formation is common during medical procedures such as surgery. Heparin is an anticoagulant drug that is used for the prevention of blood clot formation. The major reason behind the rising heparin market is increased cases of blood clots. This is due to increased chronic diseases, such as cardiovascular diseases, cancer, and others.